About Delfi Diagnostics
Delfi Diagnostics is a company based in Baltimore (United States) founded in 2019.. Delfi Diagnostics has raised $331.59 million across 6 funding rounds from investors including Lilly, Brown Advisory and TD Securities. Delfi Diagnostics offers products and services including DELFI Method and CASCADE-LUNG Trial. Delfi Diagnostics operates in a competitive market with competitors including Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others.
- Headquarter Baltimore, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Delfi Diagnostics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$331.59 M (USD)
in 6 rounds
-
Latest Funding Round
$34.33 M (USD), Debt – Conventional
Dec 01, 2025
-
Investors
Lilly
& 18 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delfi Diagnostics
Delfi Diagnostics offers a comprehensive portfolio of products and services, including DELFI Method and CASCADE-LUNG Trial. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Analyzes cell-free DNA fragments for early cancer screening.
Evaluates fragmentomics technology for lung cancer detection.
Unlock access to complete
Unlock access to complete
Software Development Team
27 people
Leadership Team
15 people
Advisor Team
8 people
Senior Team
8 people
Board Team
5 people
Product Management Team
5 people
Staff Team
4 people
Data Analysis and Operations Team
4 people
Unlock access to complete
Funding Insights of Delfi Diagnostics
Delfi Diagnostics has successfully raised a total of $331.59M across 6 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $34.33 million completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Debt – Conventional — $34.3M
-
First Round
First Round
(18 Jun 2018)
- Investors Count 19
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2025 | Amount | Debt – Conventional - Delfi Diagnostics | Valuation |
investors |
|
| Jun, 2024 | Amount | Series B - Delfi Diagnostics | Valuation | Merck Global Health Innovation Fund |
|
| Jul, 2022 | Amount | Series B - Delfi Diagnostics | Valuation | DFJ Growth |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Delfi Diagnostics
Delfi Diagnostics has secured backing from 19 investors, including venture fund and institutional investors. Prominent investors backing the company include Lilly, Brown Advisory and TD Securities. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward innovative technology startups by DFJ Growth.
|
Founded Year | Domain | Location | |
|
No specific business activity is described for this entity.
|
Founded Year | Domain | Location | |
|
PTX Capital is involved in capital investment activities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Delfi Diagnostics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Delfi Diagnostics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Delfi Diagnostics Comparisons
Competitors of Delfi Diagnostics
Delfi Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Natera, Foundation Medicine and ArcherDX, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Circulating tumor DNA is screened for early cancer detection.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Delfi Diagnostics
Frequently Asked Questions about Delfi Diagnostics
When was Delfi Diagnostics founded?
Delfi Diagnostics was founded in 2019.
Where is Delfi Diagnostics located?
Delfi Diagnostics is headquartered in Baltimore, United States. It is registered at Baltimore, Maryland, United States.
Who is the current CEO of Delfi Diagnostics?
Susan Tousi is the current CEO of Delfi Diagnostics.
Is Delfi Diagnostics a funded company?
Delfi Diagnostics is a funded company, having raised a total of $331.59M across 6 funding rounds to date. The company's 1st funding round was a Series B of $225M, raised on Jun 18, 2018.
What does Delfi Diagnostics do?
Delfi Diagnostics was founded in 2019 and is based in Baltimore, United States. Operations focus on the biotechnology sector, where a platform employing artificial intelligence and whole genome sequencing is utilized to identify DNA fragmentation patterns in patient blood samples. Services are centered on early cancer detection through non-invasive liquid biopsy methods, supporting diagnostic applications in oncology.
Who are the top competitors of Delfi Diagnostics?
Delfi Diagnostics's top competitors include Guardant Health, GRAIL and Foundation Medicine.
What products or services does Delfi Diagnostics offer?
Delfi Diagnostics offers DELFI Method and CASCADE-LUNG Trial.
Who are Delfi Diagnostics's investors?
Delfi Diagnostics has 19 investors. Key investors include Lilly, Brown Advisory, TD Securities, Orbimed, and DFJ Growth.